Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

A black-blood ultra-short echo time (UTE) sequence for 3D isotropic resolution imaging of the lungs.

Delacoste J, Feliciano H, Yerly J, Dunet V, Beigelman-Aubry C, Ginami G, van Heeswijk RB, Piccini D, Stuber M, Sauty A.

Magn Reson Med. 2019 Jun;81(6):3808-3818. doi: 10.1002/mrm.27679. Epub 2019 Feb 8.

PMID:
30737836
2.

Diagnosis and Management of Asthma - The Swiss Guidelines.

Rothe T, Spagnolo P, Bridevaux PO, Clarenbach C, Eich-Wanger C, Meyer F, Miedinger D, Möller A, Nicod LP, Nicolet-Chatelain G, Sauty A, Steurer-Stey C, Leuppi JD.

Respiration. 2018;95(5):364-380. doi: 10.1159/000486797. Epub 2018 Apr 3.

3.

A double echo ultra short echo time (UTE) acquisition for respiratory motion-suppressed high resolution imaging of the lung.

Delacoste J, Chaptinel J, Beigelman-Aubry C, Piccini D, Sauty A, Stuber M.

Magn Reson Med. 2018 Apr;79(4):2297-2305. doi: 10.1002/mrm.26891. Epub 2017 Aug 30.

PMID:
28856720
4.

Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients.

Panchaud A, Di Paolo ER, Koutsokera A, Winterfeld U, Weisskopf E, Baud D, Sauty A, Csajka C.

Respiration. 2016;91(4):333-48. doi: 10.1159/000444088. Epub 2016 Mar 5. Review.

6.

CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma.

Pellaton-Longaretti C, Boudousquié C, Barbier N, Barbey C, Argiroffo CB, Donati Y, Sauty A, Spertini F.

Int Immunol. 2011 Jan;23(1):17-27. doi: 10.1093/intimm/dxq453. Epub 2010 Dec 1.

PMID:
21123830
7.

[The hyperventilation syndrome].

Sauty A, Prosper M.

Rev Med Suisse. 2008 Nov 19;4(180):2500, 2502-5. Review. French.

PMID:
19127893
8.

[Pneumology. Anti-IgE antibodies in the treatment of asthma].

Leuenberger P, Sauty A, Rochat T.

Rev Med Suisse. 2007 Jan 10;3(93):56-9. Review. French.

PMID:
17354662
9.

[Lake Geneva Region guidelines on management of adult asthma].

Taramarcaz P, Rutschmann O, Hugli O, Rochat T, Leimgruber A, Sauty A, Hauser C, Janssens JP.

Rev Med Suisse. 2006 Apr 19;2(62):1022-7, 1029-33. French.

PMID:
16711146
10.

[Hemoptysis: methods of localization].

Laurent F, Martins M, Sauty A.

Rev Med Suisse. 2005 Nov 16;1(41):2659-63. Review. French.

PMID:
16355880
11.

Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.

Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, Hug C, Pilet M, Roulet M.

Clin Nutr. 2006 Jun;25(3):418-27. Epub 2005 Dec 2.

PMID:
16325968
12.

[Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].

Kernen Y, Sauty A, Roulet M.

Rev Med Suisse. 2005 Mar 2;1(9):637-8, 640. Review. French.

PMID:
15813341
13.

Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.

Eperon S, Sauty A, Lanz R, Leimgruber A, Lurati F, Guex-Crosier Y.

Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):966-70. Epub 2004 Jun 25.

PMID:
15221302
14.

[Lung transplantation in cystic fibrosis].

Sauty A, Rappaz I, Aubert JD.

Rev Med Suisse Romande. 2002 Jun;122(6):301-3. Review. French. Erratum in: Rev Med Suisse Romande 2002 Aug;122(8):following 413.

PMID:
12174691
15.

IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma.

Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD.

J Immunol. 2002 May 15;168(10):5278-86.

16.

CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

Sauty A, Colvin RA, Wagner L, Rochat S, Spertini F, Luster AD.

J Immunol. 2001 Dec 15;167(12):7084-93.

17.

Protective effects of hypercapnic acidosis on ventilator-induced lung injury.

Broccard AF, Hotchkiss JR, Vannay C, Markert M, Sauty A, Feihl F, Schaller MD.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):802-6.

PMID:
11549536
18.

CC chemokine receptor-2 is not essential for the development of antigen-induced pulmonary eosinophilia and airway hyperresponsiveness.

MacLean JA, De Sanctis GT, Ackerman KG, Drazen JM, Sauty A, DeHaan E, Green FH, Charo IF, Luster AD.

J Immunol. 2000 Dec 1;165(11):6568-75.

19.

Chemokines, leukocytes, and atherosclerosis.

Gerszten RE, Mach F, Sauty A, Rosenzweig A, Luster AD.

J Lab Clin Med. 2000 Aug;136(2):87-92. Review. No abstract available.

PMID:
10945236
20.

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.

Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD.

J Immunol. 2000 Jun 15;164(12):6503-8.

21.

The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.

Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD.

Circ Res. 2000 Feb 4;86(2):131-8.

PMID:
10666407
22.

Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations.

Pecherstorfer M, Jilch R, Sauty A, Horn E, Keck AV, Zimmer-Roth I, Thiebaud D.

J Bone Miner Res. 2000 Jan;15(1):147-54.

23.

Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1.

Aubert V, Schneeberger D, Sauty A, Winter J, Sperisen P, Aubert JD, Spertini F.

Infect Immun. 2000 Jan;68(1):120-4.

24.

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.

Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD.

J Clin Invest. 1999 Oct;104(8):1041-50.

25.

In vitro and in vivo responses of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67).

Wang C, Bozza PT, Barbashov SF, Sauty A, Nicholson-Weller A.

Clin Exp Immunol. 1999 Aug;117(2):261-8.

26.

The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD.

J Immunol. 1999 Mar 15;162(6):3549-58.

27.

Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice.

MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT.

Am J Respir Cell Mol Biol. 1999 Mar;20(3):379-87.

PMID:
10030835
28.

Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils.

Huang WW, Garcia-Zepeda EA, Sauty A, Oettgen HC, Rothenberg ME, Luster AD.

J Exp Med. 1998 Sep 21;188(6):1063-74.

29.

Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.

Fallab-Stubi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M.

Int J Tuberc Lung Dis. 1998 Jul;2(7):525-30.

PMID:
9661817
30.

IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils.

Elovic AE, Ohyama H, Sauty A, McBride J, Tsuji T, Nagai M, Weller PF, Wong DT.

J Immunol. 1998 Jun 15;160(12):6121-7.

31.

Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies.

Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, Nicod LP.

Eur Respir J. 1997 Dec;10(12):2907-12.

32.

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates.

Thiébaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P.

Calcif Tissue Int. 1997 Nov;61(5):386-92.

PMID:
9351880
33.

Epitope-specific engagement of the protein tyrosine phosphatase CD45 induces tumor necrosis factor-alpha gene expression via transcriptional mechanisms.

Estoppey O, Sauty A, Espel E, Menoud Z, Frei PC, Spertini F.

Eur J Immunol. 1996 Jul;26(7):1475-80.

PMID:
8766549
34.

Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy.

Sauty A, Pecherstorfer M, Zimmer-Roth I, Fioroni P, Juillerat L, Markert M, Ludwig H, Leuenberger P, Burckhardt P, Thiebaud D.

Bone. 1996 Feb;18(2):133-9.

PMID:
8833207
35.

Differences in PO2 and PCO2 between arterial and arterialized earlobe samples.

Sauty A, Uldry C, Debétaz LF, Leuenberger P, Fitting JW.

Eur Respir J. 1996 Feb;9(2):186-9.

36.

Cytostatic activity of alveolar macrophages from smokers and nonsmokers: role of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha.

Sauty A, Mauel J, Philippeaux MM, Leuenberger P.

Am J Respir Cell Mol Biol. 1994 Nov;11(5):631-7.

PMID:
7946392
37.

Dietary vitamin C intake and concentrations in the body fluids and cells of male smokers and nonsmokers.

Bui MH, Sauty A, Collet F, Leuenberger P.

J Nutr. 1992 Feb;122(2):312-6.

PMID:
1732471

Supplemental Content

Support Center